Publications

Filter results by

Filtered by:

Roger Kim

List of Publications

Title Date PC3I Authors Journal
Impact of the COVID-19 pandemic on treatment patterns for US patients with metastatic solid cancer October 6, 2021
PC3I Authors
Samuel Takvorian; Daniel Lee; Roger Kim; Ronac Mamtani; Larry Shulman; William Ferrell; Caleb M. Hearn
medRxiv
Impact of the COVID-19 Pandemic on Treatment Patterns for Patients With Metastatic Solid Cancer in the United States December 11, 2021
PC3I Authors
Samuel Takvorian; Daniel Lee; Roger Kim; Caleb M. Hearn; William Ferrell; Larry Shulman; Ronac Mamtani
Journal of the National Cancer Institute
Racial Disparities in Adherence to Annual Lung Cancer Screening and Recommended Follow-Up Care: A Multicenter Cohort Study February 15, 2022
PC3I Authors
Roger Kim; Katharine Rendle; Anil Vachani
Annals of the American Thoracic Society
Artificial Intelligence Tool for Assessment of Indeterminate Pulmonary Nodules Detected with CT May 24, 2022
PC3I Authors
Roger Kim; Anil Vachani
Radiology
Diagnostic Yield of Cone-beam-Derived Augmented Fluoroscopy and Ultrathin Bronchoscopy Versus Conventional Navigational Bronchoscopy Techniques August 3, 2022
PC3I Authors
Roger Kim; Anil Vachani
Journal of Bronchology and Interventional Pulmonology
Socioeconomic Status as a Mediator of Racial Disparity in Annual Lung Cancer Screening Adherence October 28, 2022
PC3I Authors
Roger Kim; Katharine Rendle; Anil Vachani
American Journal of Respiratory and Critical Care Medicine
Effect of an artificial intelligence tool on management decisions for indeterminate pulmonary nodules April 5, 2023
PC3I Authors
Roger Kim; Anil Vachani
Respirology
Social vulnerability and lung malignancy mortality November 17, 2023
PC3I Authors
Roger Kim
Journal of Cancer Policy
Rates of Downstream Procedures and Complications Associated With Lung Cancer Screening in Routine Clinical Practice : A Retrospective Cohort Study January 1, 2024
PC3I Authors
Katharine Rendle; Anil Vachani; Roger Kim; Jocelyn Wainwright
Annals of Internal Medicine
Radiomics and artificial intelligence for risk stratification of pulmonary nodules: Ready for primetime? March 1, 2024
PC3I Authors
Roger Kim
Cancer Biomarkers
Comparative effectiveness of second-line immune checkpoint inhibitor therapy versus chemotherapy for malignant pleural mesothelioma July 28, 2021
PC3I Authors
Roger Kim; Anil Vachani; Katharine Rendle
Lung Cancer